$CAH
CARDINAL HEALTH INC

2020 Q4 Form 10-Q Financial Statement

#000072137121000011 Filed on February 05, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $41.54B $39.74B
YoY Change 4.55% 5.29%
Cost Of Revenue $39.77B $38.02B
YoY Change 4.59% 5.58%
Gross Profit $1.776B $1.714B
YoY Change 3.62% -0.92%
Gross Profit Margin 4.28% 4.31%
Selling, General & Admin $1.147B $1.163B
YoY Change -1.38% 9.3%
% of Gross Profit 64.58% 67.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $199.0M $230.0M
YoY Change -13.48% -9.09%
% of Gross Profit 11.2% 13.42%
Operating Expenses $1.147B $1.163B
YoY Change -1.38% 9.3%
Operating Profit $461.0M $334.0M
YoY Change 38.02% -33.73%
Interest Expense $46.00M $63.00M
YoY Change -26.98% -17.11%
% of Operating Profit 9.98% 18.86%
Other Income/Expense, Net $12.00M $12.00M
YoY Change 0.0% -157.14%
Pretax Income $427.0M $279.0M
YoY Change 53.05% -31.45%
Income Tax -$203.0M -$59.00M
% Of Pretax Income -47.54% -21.15%
Net Earnings $629.0M $220.0M
YoY Change 185.91% -21.43%
Net Earnings / Revenue 1.51% 0.55%
Basic Earnings Per Share
Diluted Earnings Per Share $2.132M $748.3K
COMMON SHARES
Basic Shares Outstanding 294.0M shares 292.0M shares
Diluted Shares Outstanding 295.0M shares 294.0M shares

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.737B $1.659B
YoY Change 125.26% -23.97%
Cash & Equivalents $3.737B $1.659B
Short-Term Investments
Other Short-Term Assets $3.205B $1.998B
YoY Change 60.41% 2.99%
Inventory $14.44B $13.80B
Prepaid Expenses
Receivables $8.728B $8.280B
Other Receivables $0.00 $0.00
Total Short-Term Assets $30.11B $25.74B
YoY Change 17.01% 2.57%
LONG-TERM ASSETS
Property, Plant & Equipment $2.386B $2.301B
YoY Change 3.69% -3.16%
Goodwill $8.399B $8.356B
YoY Change 0.51% 0.47%
Intangibles $2.703B $3.167B
YoY Change -14.65% -13.38%
Long-Term Investments
YoY Change
Other Assets $1.118B $1.482B
YoY Change -24.56% 45.01%
Total Long-Term Assets $14.61B $15.31B
YoY Change -4.57% -0.42%
TOTAL ASSETS
Total Short-Term Assets $30.11B $25.74B
Total Long-Term Assets $14.61B $15.31B
Total Assets $44.72B $41.04B
YoY Change 8.96% 1.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.24B $21.50B
YoY Change 8.07% 4.32%
Accrued Expenses $2.502B $2.239B
YoY Change 11.75% 26.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $13.00M $1.192B
YoY Change -98.91% -17.79%
Total Short-Term Liabilities $25.75B $24.89B
YoY Change 3.46% 4.47%
LONG-TERM LIABILITIES
Long-Term Debt $6.720B $6.742B
YoY Change -0.33% -11.28%
Other Long-Term Liabilities $324.0M
YoY Change
Total Long-Term Liabilities $6.720B $7.066B
YoY Change -4.9% -7.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.75B $24.89B
Total Long-Term Liabilities $6.720B $7.066B
Total Liabilities $42.75B $40.04B
YoY Change 6.76% 16.34%
SHAREHOLDERS EQUITY
Retained Earnings $1.255B $449.0M
YoY Change 179.51% -91.42%
Common Stock $2.778B $2.752B
YoY Change 0.94% 0.88%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.009B $2.099B
YoY Change -4.29% 16.94%
Treasury Stock Shares 33.00M shares 35.00M shares
Shareholders Equity $1.971B $999.0M
YoY Change
Total Liabilities & Shareholders Equity $44.72B $41.04B
YoY Change 8.96% 1.43%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $629.0M $220.0M
YoY Change 185.91% -21.43%
Depreciation, Depletion And Amortization $199.0M $230.0M
YoY Change -13.48% -9.09%
Cash From Operating Activities $1.217B $697.0M
YoY Change 74.61% 87.87%
INVESTING ACTIVITIES
Capital Expenditures -$96.00M -$77.00M
YoY Change 24.68% 32.76%
Acquisitions
YoY Change
Other Investing Activities -$1.000M -$1.000M
YoY Change 0.0% -96.15%
Cash From Investing Activities -$97.00M -$78.00M
YoY Change 24.36% -7.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -146.0M -175.0M
YoY Change -16.57% 21.53%
NET CHANGE
Cash From Operating Activities 1.217B 697.0M
Cash From Investing Activities -97.00M -78.00M
Cash From Financing Activities -146.0M -175.0M
Net Change In Cash 974.0M 444.0M
YoY Change 119.37% 210.49%
FREE CASH FLOW
Cash From Operating Activities $1.217B $697.0M
Capital Expenditures -$96.00M -$77.00M
Free Cash Flow $1.313B $774.0M
YoY Change 69.64% 80.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000721371
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-11373
dei Entity Registrant Name
EntityRegistrantName
Cardinal Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0958666
dei Entity Address Address Line1
EntityAddressAddressLine1
7000 Cardinal Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43017
dei City Area Code
CityAreaCode
(614)
dei Local Phone Number
LocalPhoneNumber
757-5000
dei Security12b Title
Security12bTitle
Common shares (without par value)
dei Trading Symbol
TradingSymbol
CAH
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
293667560 shares
CY2020Q4 us-gaap Revenues
Revenues
41541000000 USD
CY2019Q4 us-gaap Revenues
Revenues
39735000000 USD
us-gaap Revenues
Revenues
80606000000 USD
us-gaap Revenues
Revenues
77076000000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39765000000 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38021000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
77115000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
73683000000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
1776000000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
1714000000 USD
us-gaap Gross Profit
GrossProfit
3491000000 USD
us-gaap Gross Profit
GrossProfit
3393000000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1147000000 USD
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1163000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2284000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2270000000 USD
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
20000000 USD
CY2019Q4 us-gaap Restructuring Charges
RestructuringCharges
56000000 USD
us-gaap Restructuring Charges
RestructuringCharges
57000000 USD
us-gaap Restructuring Charges
RestructuringCharges
86000000 USD
CY2020Q4 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
116000000 USD
CY2019Q4 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
133000000 USD
cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
234000000 USD
cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
265000000 USD
CY2020Q4 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2019Q4 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-7000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-9000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-8000000 USD
CY2020Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-32000000 USD
CY2019Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-21000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1070000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5694000000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
461000000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
334000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-163000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4930000000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
46000000 USD
CY2019Q4 us-gaap Interest Expense
InterestExpense
63000000 USD
us-gaap Interest Expense
InterestExpense
91000000 USD
us-gaap Interest Expense
InterestExpense
129000000 USD
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
427000000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
279000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-236000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5065000000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
203000000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-59000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
613000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
364000000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
630000000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
220000000 USD
us-gaap Profit Loss
ProfitLoss
377000000 USD
us-gaap Profit Loss
ProfitLoss
-4701000000 USD
CY2020Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2019Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
629000000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
220000000 USD
us-gaap Net Income Loss
NetIncomeLoss
376000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4702000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.14
CY2019Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.75
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.28
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-15.99
CY2020Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.13
CY2019Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.75
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.27
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-15.99
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
292000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
293000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
294000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
294000000 shares
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4859
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4811
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.9718
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.9622
CY2020Q4 us-gaap Profit Loss
ProfitLoss
630000000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
220000000 USD
us-gaap Profit Loss
ProfitLoss
377000000 USD
us-gaap Profit Loss
ProfitLoss
-4701000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
33000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
13000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1000000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
18000000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-6000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
34000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
51000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-24000000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
664000000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
218000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
428000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4725000000 USD
CY2020Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2019Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
663000000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
218000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
427000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4726000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3737000000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2771000000 USD
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8728000000 USD
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
8264000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
14443000000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
13198000000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3205000000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1707000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
30113000000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
25940000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2386000000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2366000000 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11102000000 USD
CY2020Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11275000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1118000000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1185000000 USD
CY2020Q4 us-gaap Assets
Assets
44719000000 USD
CY2020Q2 us-gaap Assets
Assets
40766000000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23235000000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
21374000000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
13000000 USD
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
10000000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2502000000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2231000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25750000000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23615000000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6720000000 USD
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6765000000 USD
CY2020Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
10274000000 USD
CY2020Q2 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
8594000000 USD
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2778000000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
2789000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1255000000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1170000000 USD
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
33000000 shares
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
34000000 shares
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2009000000 USD
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2066000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53000000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-104000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1971000000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1789000000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
4000000 USD
CY2020Q2 us-gaap Minority Interest
MinorityInterest
3000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1975000000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1792000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44719000000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40766000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1425000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
629000000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
630000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
34000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
34000000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
30000000 USD
CY2020Q4 us-gaap Dividends
Dividends
144000000 USD
CY2020Q4 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1975000000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
903000000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
220000000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
220000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
23000000 USD
CY2019Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
CY2019Q4 us-gaap Dividends
Dividends
143000000 USD
CY2019Q4 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1002000000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1792000000 USD
us-gaap Net Income Loss
NetIncomeLoss
376000000 USD
us-gaap Profit Loss
ProfitLoss
377000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
51000000 USD
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2000000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
46000000 USD
us-gaap Dividends
Dividends
289000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-2000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1975000000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6330000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4702000000 USD
us-gaap Profit Loss
ProfitLoss
-4701000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-24000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
30000000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
350000000 USD
us-gaap Dividends
Dividends
284000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
1000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1002000000 USD
us-gaap Profit Loss
ProfitLoss
377000000 USD
us-gaap Profit Loss
ProfitLoss
-4701000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
404000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
464000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-9000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-8000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
51000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
41000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
35000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
47000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
499000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-121000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1256000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
991000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1861000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-77000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-504000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-5128000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1487000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
174000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
149000000 USD
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
18000000 USD
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
6000000 USD
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
4000000 USD
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
2000000 USD
cah Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
0 USD
cah Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
2000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-191000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
681000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
49000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
793000000 USD
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-6000000 USD
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-11000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
289000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
287000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
350000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-344000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-760000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
14000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
966000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-872000000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2771000000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2531000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3737000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1659000000 USD
CY2020Q4 us-gaap Severance Costs1
SeveranceCosts1
8000000 USD
CY2019Q4 us-gaap Severance Costs1
SeveranceCosts1
42000000 USD
CY2020Q4 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
12000000 USD
CY2019Q4 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
14000000 USD
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
20000000 USD
CY2019Q4 us-gaap Restructuring Charges
RestructuringCharges
56000000 USD
us-gaap Severance Costs1
SeveranceCosts1
32000000 USD
us-gaap Severance Costs1
SeveranceCosts1
62000000 USD
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
25000000 USD
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
24000000 USD
us-gaap Restructuring Charges
RestructuringCharges
57000000 USD
us-gaap Restructuring Charges
RestructuringCharges
86000000 USD
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
96000000 USD
us-gaap Restructuring Costs
RestructuringCosts
41000000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
53000000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
84000000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
8357000000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2000000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
40000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
8399000000 USD
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
24000000 USD
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
24000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5853000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3174000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2679000000 USD
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P12Y
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5877000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3174000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2703000000 USD
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
23000000 USD
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
23000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5831000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2936000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2895000000 USD
CY2020Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5854000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2936000000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2918000000 USD
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
113000000 USD
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
127000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
228000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
256000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
217000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
398000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
359000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
329000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
278000000 USD
CY2020Q4 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
6700000000 USD
CY2020Q2 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
6800000000 USD
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
23200000000 USD
CY2020Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
21400000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 USD
CY2019Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4000000 USD
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.476
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.597
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.072
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
989000000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
998000000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
745000000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
753000000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
150000000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
146000000 USD
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
CY2020Q4 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
CY2019Q4 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
CY2020Q4 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
6733000000 USD
CY2020Q2 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
6775000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
350000000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
292000000 shares
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2019Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
294000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
293000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
295000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
294000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000000 shares
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000000 shares
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000000 shares
cah Sharesthatwouldbeantidilutiveasaresultofnetloss
Sharesthatwouldbeantidilutiveasaresultofnetloss
1000000 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q4 us-gaap Revenues
Revenues
41541000000 USD
CY2019Q4 us-gaap Revenues
Revenues
39735000000 USD
us-gaap Revenues
Revenues
80606000000 USD
us-gaap Revenues
Revenues
77076000000 USD
CY2020Q4 us-gaap Revenues
Revenues
41541000000 USD
CY2019Q4 us-gaap Revenues
Revenues
39735000000 USD
us-gaap Revenues
Revenues
80606000000 USD
us-gaap Revenues
Revenues
77076000000 USD
CY2020Q4 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
6000000 USD
CY2019Q4 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
17000000 USD
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
11000000 USD
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
20000000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
461000000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
334000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-163000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4930000000 USD
CY2020Q4 us-gaap Assets
Assets
44719000000 USD
CY2020Q2 us-gaap Assets
Assets
40766000000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23000000 USD
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41000000 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5000000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
65.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5000000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
67.08
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5000000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
67.27

Files In Submission

Name View Source Status
0000721371-21-000011-index-headers.html Edgar Link pending
0000721371-21-000011-index.html Edgar Link pending
0000721371-21-000011.txt Edgar Link pending
0000721371-21-000011-xbrl.zip Edgar Link pending
a21q2_10qx123120xexhibit311.htm Edgar Link pending
a21q2_10qx123120xexhibit312.htm Edgar Link pending
a21q2_10qx123120xexhibit321.htm Edgar Link pending
a21q2_10qx123120xexhibit991.htm Edgar Link pending
cah-20201231.htm Edgar Link pending
cah-20201231.xsd Edgar Link pending
cah-20201231_cal.xml Edgar Link unprocessable
cah-20201231_def.xml Edgar Link unprocessable
cah-20201231_g1.jpg Edgar Link pending
cah-20201231_g2.jpg Edgar Link pending
cah-20201231_g3.jpg Edgar Link pending
cah-20201231_g4.jpg Edgar Link pending
cah-20201231_g5.jpg Edgar Link pending
cah-20201231_g6.jpg Edgar Link pending
cah-20201231_g7.jpg Edgar Link pending
cah-20201231_htm.xml Edgar Link completed
cah-20201231_lab.xml Edgar Link unprocessable
cah-20201231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending